RNF213 Antikörper (AA 202-350)
Kurzübersicht für RNF213 Antikörper (AA 202-350) (ABIN7151176)
Target
Alle RNF213 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 202-350
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human E3 ubiquitin-protein ligase RNF213 protein (202-350AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:500-1:1000, IF:1:200-1:500,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- RNF213 (Ring Finger Protein 213 (RNF213))
-
Andere Bezeichnung
- RNF213
-
Hintergrund
-
Background: E3 ubiquitin-protein ligase involved in angiogenesis (PubMed:21799892, PubMed:26278786, PubMed:26766444, PubMed:26126547). Involved in the non-canonical Wnt signaling pathway in vascular development: acts by mediating ubiquitination and degradation of FLNA and NFATC2 downstream of RSPO3, leading to inhibit the non-canonical Wnt signaling pathway and promoting vessel regression (PubMed:26766444). Also has ATPase activity (PubMed:24658080, PubMed:26126547).
Aliases: ALK lymphoma oligomerization partner on chromosome 17 antibody, C17orf27 antibody, Chromosome 17 open reading frame 27 antibody, E3 ubiquitin-protein ligase RNF213 antibody, FLJ13051 antibody, KIAA1554 antibody, MGC46622 antibody, MGC9929 antibody, MYMY2 antibody, Mysterin antibody, MYSTR antibody, NET57 antibody, RING finger protein 213 antibody, RN213_HUMAN antibody, RNF 213 antibody, RNF213 antibody
-
UniProt
- Q63HN8
Target
-